AAAAAA
Results: 1-25/32
Authors:
Imada, G
Shinkai, T
Masuda, W
Yatsui, K
Citation: G. Imada et al., Influences of floating particles produced by high-pressure, pulsed glow discharge on excimer laser excitation, JPN J A P 1, 40(2B), 2001, pp. 1144-1147
Authors:
Mizushima, H
Uchiyama, E
Nagata, H
Matsuno, Y
Sekiguchi, R
Ohmatsu, H
Hojo, F
Shimoda, T
Wakao, F
Shinkai, T
Yamaguchi, N
Moriyama, N
Kakizoe, T
Abe, K
Terada, M
Citation: H. Mizushima et al., Japanese experience of telemedicine in oncology, INT J MED I, 61(2-3), 2001, pp. 207-215
Authors:
Ohmori, O
Shinkai, T
Hori, H
Kojima, H
Nakamura, J
Citation: O. Ohmori et al., Polymorphisms of mu and delta opioid receptor genes and tardive dyskinesiain patients with schizophrenia, SCHIZOPHR R, 52(1-2), 2001, pp. 137-138
Authors:
Boku, N
Ohtsu, A
Nagashima, F
Muto, M
Shinkai, T
Yoshida, S
Citation: N. Boku et al., Retrospective study of hyponatremia in gastric cancer patients treated with a combination chemotherapy of 5-fluorouracil and cisplatin: a possible warning sign of severe hematological toxicities?, JPN J CLIN, 31(8), 2001, pp. 382-387
Authors:
Kurata, T
Tamura, T
Shinkai, T
Ohe, Y
Kunitoh, H
Kodama, T
Kakinuma, R
Matsumoto, T
Kubota, K
Omatsu, H
Nishiwaki, Y
Saijo, N
Citation: T. Kurata et al., Phase I and pharmacological study of paclitaxel given over 3 h with cisplatin for advanced non-small cell lung cancer, JPN J CLIN, 31(3), 2001, pp. 93-99
Authors:
Ohmori, O
Shinkai, T
Hori, H
Nakamura, J
Citation: O. Ohmori et al., Novel polymorphism in the 5 '-upstream region of the human 5-HT6 receptor gene and schizophrenia, NEUROSCI L, 310(1), 2001, pp. 17-20
Authors:
Hori, H
Ohmori, O
Shinkai, T
Kojima, H
Nakamura, J
Citation: H. Hori et al., Clara cell secretory protein (CC16) gene polymorphism and schizophrenia inhumans, NEUROSCI L, 298(1), 2001, pp. 75-77
Authors:
Kunitoh, H
Akiyama, Y
Kusaba, H
Yamamoto, N
Sekine, I
Ohe, Y
Kubota, K
Tamura, T
Shinkai, T
Kodama, T
Goto, K
Niho, S
Nishiwaki, Y
Saijo, N
Citation: H. Kunitoh et al., A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer, LUNG CANC, 33(2-3), 2001, pp. 259-265
Authors:
Hori, H
Ohmori, O
Shinkai, T
Kojima, H
Nakamura, J
Citation: H. Hori et al., Association between three functional polymorphisms of dopamine D2 receptorgene and tardive dyskinesia in schizophrenia, AM J MED G, 105(8), 2001, pp. 774-778
Authors:
Hori, H
Ohmori, O
Shinkai, T
Kojima, H
Nakamura, J
Citation: H. Hori et al., Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia, AM J MED G, 105(2), 2001, pp. 176-178
Authors:
Imai, T
Sasaki, Y
Shinkai, T
Ohishi, H
Nezu, K
Nishimoto, Y
Ichiba, N
Yamane, T
Yoshikawa, M
Narita, N
Uchida, H
Citation: T. Imai et al., Clinical evaluation of Tc-99m-Technegas SPECT in thoracoscopic lung volumereduction surgery in patients with pulmonary emphysema, ANN NUCL M, 14(4), 2000, pp. 263-269
Authors:
Hori, H
Ohmori, O
Shinkai, T
Kojima, H
Okano, C
Suzuki, T
Nakamura, J
Citation: H. Hori et al., Manganese superoxide dismutase gene polymorphism and schizophrenia: Relation to tardive dyskinesia, NEUROPSYCH, 23(2), 2000, pp. 170-177
Authors:
Umegaki, H
Tamaya, N
Shinkai, T
Iguchi, A
Citation: H. Umegaki et al., The metabolism of plasma glucose and catecholamines in Alzheimer's disease, EXP GERONT, 35(9-10), 2000, pp. 1373-1382
Authors:
Nakamura, Y
Kunitoh, H
Kubota, K
Sekine, I
Shinkai, T
Tamura, T
Kodama, T
Sumi, M
Kohno, S
Saijo, N
Citation: Y. Nakamura et al., Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma, JPN J CLIN, 30(9), 2000, pp. 385-388
Authors:
Fujishiro, M
Shinkai, T
Fukuda, M
Tamura, T
Ohe, Y
Kunitoh, H
Nishiwaki, Y
Sekine, I
Fukuda, H
Saijo, N
Citation: M. Fujishiro et al., Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408, JPN J CLIN, 30(11), 2000, pp. 487-493
Authors:
Ohmori, O
Shinkai, T
Hori, H
Kojima, H
Nakamura, J
Citation: O. Ohmori et al., Synapsin III gene polymorphisms and schizophrenia, NEUROSCI L, 279(2), 2000, pp. 125-127
Authors:
Terao, T
Nakamura, J
Yoshimura, R
Ohmori, O
Takahashi, N
Shinkai, T
Citation: T. Terao et al., Prediction of lithium response using m-chlorophenylpiperazine challenge test: a preliminary finding, INT CLIN PS, 15(1), 2000, pp. 39-42
Authors:
Terao, T
Nakamura, J
Yoshimura, R
Ohmori, O
Takahashi, N
Kojima, H
Soeda, S
Shinkai, T
Nakano, H
Okuno, T
Citation: T. Terao et al., Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women, PSYCHIAT R, 96(2), 2000, pp. 167-173
Authors:
Ohmori, O
Shinkai, T
Suzuki, T
Okano, C
Kojima, H
Terao, T
Nakamura, J
Citation: O. Ohmori et al., Polymorphisms of the sigma(1) receptor gene in schizophrenia: An association study, AM J MED G, 96(1), 2000, pp. 118-122
Authors:
Shinkai, T
Citation: T. Shinkai, Second mover disadvantages in a three-player Stackelberg game with privateinformation, J ECON THEO, 90(2), 2000, pp. 293-304
Authors:
Shinkai, T
Nakashima, M
Ohmori, O
Terao, T
Nakamura, J
Hiramatsu, N
Hashiguchi, H
Tsuji, S
Citation: T. Shinkai et al., Coenzyme Q(10) improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report, AUST NZ J P, 34(6), 2000, pp. 1034-1035
Authors:
Sekine, I
Tamura, T
Kunitoh, H
Kubota, K
Shinkai, T
Kamiya, Y
Saijo, N
Citation: I. Sekine et al., Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer, ANN ONCOL, 10(6), 1999, pp. 731-733
Authors:
Shinkai, T
Roth, GS
Citation: T. Shinkai et Gs. Roth, Mechanisms of age-related changes in gonadotropin-releasing hormone receptor messenger ribonucleic acid content in the anterior pituitary of male rats, EXP GERONT, 34(2), 1999, pp. 267-273
Authors:
Terao, T
Okuno, K
Okuno, T
Nakano, H
Shinkai, T
Ohmori, O
Yoshimura, R
Suzuki, T
Abe, K
Citation: T. Terao et al., A simpler and more accurate equation to predict daily lithium dose, J CL PSYCH, 19(4), 1999, pp. 336-340
Genetic association analysis between CYP2D62 allele and tardive dyskinesia in schizophrenic patients
Authors:
Ohmori, O
Kojima, H
Shinkai, T
Terao, T
Suzuki, T
Abe, K
Citation: O. Ohmori et al., Genetic association analysis between CYP2D62 allele and tardive dyskinesia in schizophrenic patients, PSYCHIAT R, 87(2-3), 1999, pp. 239-244